Sarepta Therapeutics Inc (NASDAQ:SRPT)

64.00
Delayed Data
As of Feb 16
 +0.86 / +1.36%
Today’s Change
26.96
Today|||52-Week Range
68.90
+15.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues5.4M16.3M35.0M46.0M
 
 
 
 
 
Cost of Goods Sold130.0K252.0K534.0K1.3M
 
 
 
 
 
Depreciation And Amortization1.7M1.6M1.8M2.6M
 
 
 
 
 
 
Operating ExpensesGross Income3.6M14.5M32.7M42.1M
 
 
 
 
 
General Expenses92.0M53.5M90.7M62.4M
 
 
 
 
 
Research And Development70.7M29.0M58.8M34.2M
 
 
 
 
 
Total Operating Expenses93.8M55.4M93.0M66.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-88.4M-39.0M-58.0M-20.3M
 
 
 
 
 
Extraordinary Credit0.00125.0M0.000.00
 
 
Extraordinary Charge0.00-236.0K-5.4M-25.6M
 
 
 
 
Interest Expense On Debt57.0K------
 
 
Other Expenses0.00335.0K184.0K184.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-88.5M86.1M-63.2M-45.7M
 
 
 
 
 
Income Taxes0.00-2.0M-109.0K-2.0M
 
 
 
 
Net Income-88.5M84.1M-63.0M-47.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS54.6M54.9M55.0M61.5M
 
 
 
 
 
Shares To Calculate EPS Diluted54.6M56.0M55.0M61.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.62$1.50-$1.15-$0.78
 
 
 
 
 
EPS Diluted-$1.62$1.50-$1.15-$0.78